外文數(shù)據(jù)庫(kù)上機(jī)實(shí)習(xí)報(bào)告

1、外文數(shù)據(jù)庫(kù)上機(jī)實(shí)習(xí)報(bào)告姓名：陶鳳學(xué)號(hào)： 099104121班級(jí)：商 092 班教師姓名：盛功平+1利用Elsevier 的Scienee Direct 數(shù)據(jù)庫(kù)檢索：礒 (1 )、利用“快速檢索”檢索數(shù)字圖書(shū)館中的元數(shù)據(jù)研究這一課題的文獻(xiàn)。關(guān)鍵詞： 數(shù)字圖書(shū)館(digital library )；元數(shù)據(jù)(metadata )。要求：列出你的檢索表達(dá)式; 輸出2-3篇題錄式檢索結(jié)果。檢索表達(dá)式：digital library and metadataLibrary Collections,Acquisitions,30, Issues 1-2, March-June 2006 ,Jin MaOri

2、gi nal Research Article and Technical Services , Volume Pages 3-17Lt Show preview | PDF (181 K)| Related articles| Related reference workarticlesin a library setting:Links (CAMEL)projectthe Collectio n at Oreg on StateUn iversityOrigi nal Research ArticleLibrary Collections, Acquisitions, and Techni

3、cal Services , Volume 24, Issue 2 , Summer 2000 Pages 217-227Kyle Ban erjeeE Show previewV PDF (147 K)| Related articles| Related reference workOrigi nalarticlesIn formatio n red undancy across metadata collect ionsResearch ArticleInformation Processing & Managemer,t Volume 43, Issue 3, May2007, Pag

4、es 740-751Muriel Foulonn eauShow previewPDF (682 K)| Related articles| Related reference workarticles噸 (2)、利用“高級(jí)檢索” 檢索關(guān)于藥物上癮治療方法的研究，限定：關(guān)鍵詞出現(xiàn)在“題名-摘要-關(guān)鍵詞”字段，2002年以來(lái)發(fā)表的文章，限定在醫(yī)學(xué)領(lǐng)域內(nèi)查找。關(guān)鍵詞:藥物(drug )、上癮(addiction )、治療方法(therapy)；要求：列出你的檢索表達(dá)式 和檢索步驟；列出 2-3篇文摘式檢索結(jié)果。檢索表達(dá)式和檢索步驟：進(jìn)入安徽工業(yè)大學(xué)圖書(shū)館網(wǎng)頁(yè)，點(diǎn)擊Elsevier數(shù)據(jù)庫(kù)，進(jìn)入頁(yè)面,

5、檢索表達(dá)式為 drug and addiction and therapy.點(diǎn)擊 searchPsychologie Fran ?aiseArticle in Press, Corrected Proof - Note to usersdoi:10.1016/j.psfr.2010.10.001| How to Cite or Link Using DOICopyright ? 2010 Soci et efran ?aise de psychologie Published by Elsevier Masson SASPermissions & ReprintsArticle origi n

6、alExiste-t-il une typologie familiale dans les pathologies addictives? Revuecritique de la litterature sur les familles ddolesce nts pr esentant des troublesalime ntaires ou des con duites de dSpendance aux substa ncesIs there a family typology of addictive behaviors? Critical review of the literatu

7、rein the families of adolesce nts with an eat ing disorder or with asubsta nce-depe ndenceK. Dobaand J.-L. Nandrino2, a,a EA1059, unitede recherche en sciences cognitives et affectives (URECA), universite Lille-3,35, rue Sainte-Barbe, BP 70460, 59208 Tourcoing, FranceReceived 7 June 2010;accepted 16

8、 October 2010.Available online 20 November 2010.eistiques duResumeParmi les facteurs favorisant les conduites addictives, certaines caractfonctionnement familial sont souventevoqu ees dans les troubles alimentaires et dans lesd ependances aux substances psychoactives ou al alcool. La mise a l pfeuve

9、 des observations des processus familiaux par des recherches empiriques int egrant diff eents niveaux epist emologiques et m ethodologiques a conduit a des r esultats contradictoires concernant les diffeentes formesde fonctionnementsfamiliaux associ e aces pathologiesaddictives. Cet article propose

10、une revuecritique de la litterature dans le cadre des conceptions syst emiques concernant les d er eglementsfamiliaux impliqu es dans l apparitiondes troubles alimentaires et des d ependances aux substancesou al alcool chez les adolescents. Il sagira egalement de discuter la similaritedeshypoth ese

11、d une typologiecaract eristiques familiales entre ces pathologies addictives et l familiale propre aux conduites addictives.AbstractAmong factors favoring the addictive behaviors, some specific family processes are often identified in eating disorders and dependences with psychoactive substances. Di

12、fferent models of systemic orientation described the familial disturbances involved in the addictive pathologies emphasizing either the emotional interaction and the processes of differentiation family, either the structure and the level of family cohesion. This article proposes a critical review of

13、 the systemic literature on the familial disturbances involved in the families of adolescents with eating disorders or with a substance-dependence. The systemic models (Bowen, Minuchin) are reference values in the understanding of family processes and therapy with families. Theobservations of these

14、family processes have been confronted to empirical researches integrating different epistemological levels and different methods. The empirical results are heterogenous concerning the different forms of family functioning associated with these addictive pathologies. The empirical studies support the

15、 hypothesis of a family dysfunctioning in the different addictive behaviors and demonstrate the relationship between the severity of familial disorders and the severity of the addictive disorders. However, the family configuration described by the typological models is rarely found complete or with

16、a similar intensity between the families.The studies support the hypothesis of an emotional distance in the family interactions and a lack of parental care which could correspond to factors of chronicity or vulnerability. Comparing the family characteristics of these two types of addictive behaviors

17、, the literature supports the existence of (1) some specific family characteristics according to the type of addictive behavior (in particular the conflict avoidance which appears specifically in anorexic families) (2) some similar family patterns of interactions between the members of addictive fam

18、ilies in particular the representation of a low family cohesion, an intergenerational enmeschment and a high level of control. These family patterns suggest rather to a dimensional approach of the family characterized by different protective or risk factors. Wesuggest that these family patterns coul

19、d constitute, according to their importance (intensity and frequence), a family risk factor of development or aggravation of the addictive behaviors.Mots cl es: Addiction ; Troubles alimentaires; Dependances aux substances; Adolescence; FamilleKeywords: .Addiction 杠 Eating disorders;Drug dependence;

20、 Adolescence; FamilyArticle Outli ne1. Introduction2. Mod eles familiaux systemiques et conduites addictives3.1. Les troubles des conduites alimentaires3.1.1. Satisfaction familiale etevitement du conflit3.1.2. Niveau de cohesion et enchevetrement3.1.3. Differentes representations de la famille entr

21、e les membres3.1.4. Communication motionnelle3.2. Les conduites de dependance aux substances3.2.1. Structure familiale3.2.2. Rupture familiale3.2.3. Conflictualite3.2.4. D ependance interpersonnelle3.2.5. Perception du soin parental3.2.6. Niveau de cohesion et enchevetrement4.ConclusionConflit dt 錢(qián)

22、eReferencesProgress in Neuro-Psychopharmacology and Biological PsychiatryArticle in Press, Uncorrected Proof - Note to usersdoi:10.1016/j.p npbp.2010.11.007| How to Cite or Link Using DOICopyright ? 2010 Published by Elsevier Inc.Permissions & ReprintsPsychopharmacological comparis on of schizophre

23、nia spectrum disorder with andwithout cann abis depe ndencyZoltan Makkos a, Lilla Fejesa, Gabriella Inczedy-Farkas b, Akos Kassai-Farkasa, Gabor Faludic andc卞衛(wèi)Judit Lazary ,1st Department of Psychiatry, NyGyula Hospital, Budapest, HungaryCentre of Molecular Neurology, Semmelweis University, Budapest

24、, HungaryDepartment of Clinical and Theoretical Mental Health, Kutvolgyi Clinical Center, SemmelweisUniversity, Budapest, HungaryReceived 24 July 2010;revised 2 October 2010;accepted 5 November 2010.Available online 16 November 2010.AbstractBackgrou ndAlthough incidence of schizophrenia is higher am

25、ongcannabis users and marijuana is the most commonabused drug卜 by adolescents, etiological linkage between schizophrenia and cannabis use is stillnot clarified. Clinical experiences suggest that regular cannabis user can show similar psychoticepisode to schizophrenic disorders but it is still unclea

26、r if chronic cannabis use withschizophreniform disorder is a distinct entity requiring special* therapy 卜 or it can be treatedas classical schizophrenia. There are no data available on the comparison of pharmacotherapybetween schizophreniform patients with and without cannabis use.MethodsClinical da

27、ta of 85 patients with schizophrenia spectrum disorder were analyzed retrospectively.Cannabis use was not reported by 43 persons (Cnbs0 subgroup) and 42 patients used regularlycannabis during at least 1year (Cnbs1 subgroup). Comparison of anamnesis, family history,therapiessocial-demographic conditi

28、on, positive and negative symptoms, acute and long-termrecorded by clinical interviews was performed with chi square tests, logistic binary regressionand t-tests using SPSS 13.0 for Windows software.Results Menwere over-represented in cannabis dependent group while meanage was lower amongthem compar

29、ed to CnbsO subgroup. Prevalence of suicidal attempt was increased in men without cannabis use(OR= 5.25, p = 0.016). Patients without cannabis use spent more time in hospital (p= 0.026) andsmoking was more frequent amongthem (OR= 1.36, p = 0.047). The chance to get olanzapine for acute atherapy 卜 an

30、d aripiprazol for long termtherapy 卜 was more than two fold in Cnbs1 subgroup(OR = 2.66, OR = 3.67, respectively). However, aripiprazol was used for acute斗 therapy f withsignificantly lower risk in Cnbs1 subgroup (OR= 0.47, p = 0.023). Olanzapine was administered for long term -therapy 卜 in a higher

31、 dose to Cnbs0 patients (p = 0.040). Also higher dose of risperidon LAI was used in womenwithout cannabis dependency compared to womenof Cnbs1 subgroup (p = 0.020). Positive and negative symptoms and family history did not differ significantly between the two subgroups.Con clusi onAlthough symptom p

32、rofile was similar, hospitalization time, suicidal anamnesis, smoking habitand also dosage, intensity and lasting of-therapy were different between the two subgroups.Further prospective studies are required for the investigation of the clinical and molecular background of this discrepancy in order t

33、o determine a relevant protocol of prevention and treatment of the chronic cannabis use related psychotic disorder.Research Highlights? This is the first complex clinical comparison including pharmacotherapy between schizophrenia with and without cannabis use.? We found that although symptom profile

34、 was similar,hospitalization time, suicidal anamnesis, smoking habit and also dosage, intensity and lastingof (therapy 卜 were different between the two subgroups.? Our data suggest that besides sharedcomponents, vulnerability for cannabis use and schizophrenia and maybe also for addictive disorders

35、may have different pathogenetic factors, consequently altered molecular background and alternative pharmacological response.Keywords: Addiction ；Cannabis; Psychosis; Psychopharmacotherapy; THCAbbreviations:CB1, cannabinoid receptor 1; CGI-S, Clinical Global Impression Scale; CGI-I,Clinical Global Im

36、provement Scale; Cnbs, cannabis; HPDC,haloperidol decanoate; LAI, long acting injections; OR, odds ratioArticle Outli neintroduction2Methods3Results4Discussion5.ConclusionReferences* 2、利用El數(shù)據(jù)庫(kù)“快速檢索”檢索鋁合金表面激光溶覆研究，關(guān)鍵詞：鋁合金(Aluminum alloy )；激光溶覆(laser cladding )，限定：在“主題/題名/摘要”字段 中進(jìn)行檢索；時(shí)間是 2000年以來(lái)發(fā)表的文章。要

37、求：列出你的檢索表達(dá)式和檢索步驟， 列出2-3篇文摘式檢索結(jié)果。檢索表達(dá)式和檢索步驟：進(jìn)入安徽工業(yè)大學(xué)圖書(shū)館網(wǎng)頁(yè)，點(diǎn)擊EI數(shù)據(jù)庫(kù)，進(jìn)入頁(yè)面。檢索表達(dá)式： Alu minum alloy and laser claddi ngInternational Journal of Refractory Metals and Hard MaterialsVolume 29, Issue 1, January 2011, Pages 49-53doi:10.1016/j.ijrmhm.2010.07.001| How to Cite or Link Using DOICopyright ? 2010 El

38、sevier Ltd All rights reserved.V Permissions & ReprintsMicrostructure characteristics of Ti3AI/TiC ceramic layer deposited by lasercladd inga魁aLi Jianinga, Chen Chuanzhong a, and Zong Lei aKey Laboratory for Liquid-Solid Structural Evolution and Processing of Materials (Ministry ofEducation), Depart

39、ment of Materials Science, Shandong University, Jinan 250061, PR ChinaReceived 18 April 2010;accepted 8 July 2010.Available online 15 July 2010.AbstractAl +TiC laser cladding coatings were prepared on Ti -6Al V alloy by CO2 laser cladding technique.The microstructure, micro-hardness and phase consti

40、tutes of the laser cladding layer wereinvestigated by means of scanning electron microscope (SEM), X-ray diffraction (XRD) andmicrosclermeter. The results indicated that the laser cladding layer solidified into the fine microstructure rapidly, and TiC hard phase was dispersived in the cladding layer

41、. When the mass percent of TiC was 40%, the micro-hardness (1100HV0.2 T250HV.2) of Al + TiC cladding layer was 3times more than that of the Ti-6Al V alloy substrate (350-370HV.2). The cladding layer mainlyconsisted of a-Ti (Al),&AI (Ti),Ti 3AI, TiAl,ALTi and TiC phase. There phases were beneficialto

42、 improve the hardness and wear resistance of the cladding layer.Keywords: Titanium alloy; Laser cladding; Surface modification; Microstructure; Phase constituteArticle Outli neintroduction2Experimental2.1. Experimental materials2.2. Laser cladding process3Experimental results and analysis3.1. The mi

43、cro-hardness distribution3.2. Microstructure characteristics of laser cladding3.3. XRD and SEM analysis4ConclusionsAcknowledgementsMaterials Science and Engineering: CVolume 29, Issue 8, 15 October 2009, Pages 2392-2397doi:10.1016/j.msec.2009.07.001| How to Cite or Link Using DOICopyright ? 2009 Els

44、evier B.V. All rights reserved.；計(jì) Permissions & ReprintsAnti-tumor activity of paclitaxel-loaded chitosannanoparticles: An in vitro studyFang Li a，,Jianing Li a, Xuejun Wen b，c，ba,Shenghu Zhou , Xiaowen Tong , Pingping Su HongLia and Donglu Shi b, d,Department of Obstetrics and Gynecology, Affiliate

45、d Tenth Hospital, Tongji University, Shanghai,200072, Peoples Republic of ChinabThe Institutefor Advanced Materials and Nano Biomedicine, Tongji University, Shanghai, 200072,Peoples Republic of ChinacDepartment of Bioengineering, Clemson University, Charleston, SC, 29425, USAdDepartment of Chemical

46、& Materials Engineering, University of Cincinnati, Cincinnati, OH,45221-0012, USAReceived 3 June 2009; accepted 5 July 2009.Available online 12 July 2009.Referred to by: Corrigendum to Anti-tumor activity of paclitaxel-loaded chitosa n nan oparticles: An in vitro study” Mater. Sci.Eng., 29 (2009) 23

47、92-2397Materials Scienee and Engineering:C, Volume 30, Issue 4,10 May 2010, Page 644,Fang Li, Jia ning Li, Xuejun Wen, Shen ghu Zhou, Xiaowe n Tong, Pingping Su, Hong Li, Don glu Shi* PDF (74 K) |AbstractChitosan nanoparticles containing the anticancer drug paclitaxel were prepared by a solventevapo

48、ration and emulsification crosslinking method. The physicochemical properties of thenanoparticles were characterized by various techniques, and uniform nanoparticles with an average particle size of 116 15 nmwith high encapsulation efficiencies (EE) were obtained. Additionally, a sustained release o

49、f paclitaxel from paclitaxel-loaded chitosan nanoparticles was successful.Using different ratios of paclitaxel-to-chitosan,the EEranged from 32.2 8.21% to 94.0 16.73 %.The drug release rates of paclitaxel from the nanoparticles were approximately, 26.55 2.11% and 93.44 10.96% after 1 day and 13 days, respectively, suggesting the potential of the chitosan nanoparticles as a sustained drug delivery system. Cytotoxicity tests showed that the paclitaxel-loaded chitosan had higher cell toxicit